Literature DB >> 29705972

P-Tau and Subunit c Mitochondrial ATP Synthase Accumulation in the Central Nervous System of a Woman with Hurler-Scheie Syndrome Treated with Enzyme Replacement Therapy for 12 Years.

Hiroshi Kobayashi1,2, Masamichi Ariga3,4, Yohei Sato3,4, Masako Fujiwara4, Nei Fukasawa5, Takahiro Fukuda6, Hiroyuki Takahashi5, Masahiro Ikegami5, Motomichi Kosuga7, Torayuki Okuyama7, Yoshikatsu Eto8, Hiroyuki Ida3,4.   

Abstract

We report an autopsy case of a woman with mucopolysaccharidosis type I (MPS I) Hurler-Scheie syndrome who was treated with enzyme replacement therapy (ERT) for 12 years. This was the first case of MPS I treated with ERT in Japan. Pathological analysis showed no glycosaminoglycan accumulation in the liver and spleen as a result of long-term ERT, although severe aortic stenosis, diffuse intimal hyperplasia of the coronary artery, and fibrous hypertrophy of the endocardium were observed. Additionally, we detected subunit c mitochondrial ATP synthase (SCMAS) accumulation and mild tauopathy (hyperphosphorylated tau or p-tau, both 3-repeat and 4-repeat tau accumulation) in the same area of the cerebral limbic system and central gray matter of the mid brain and pons. Tauopathy is an important pathological finding in Alzheimer's disease and other neurodegenerative disorders; however, in MPS I, it is unclear whether tauopathy is a primary or secondary phenomenon. Thus, in this report, we describe pathological accumulation of p-tau and SCMAS in the context of MPS I and discuss the mechanisms and importance of these findings in the pathogenesis of MPS I.

Entities:  

Keywords:  Autopsy; Enzyme replacement therapy; Mucopolysaccharidosis type I; Subunit c mitochondrial ATP synthase; Tauopathy

Year:  2018        PMID: 29705972      PMCID: PMC6122043          DOI: 10.1007/8904_2018_106

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  23 in total

1.  Delivery of an enzyme-IGFII fusion protein to the mouse brain is therapeutic for mucopolysaccharidosis type IIIB.

Authors:  Shih-Hsin Kan; Mika Aoyagi-Scharber; Steven Q Le; Jon Vincelette; Kazuhiro Ohmi; Sherry Bullens; Daniel J Wendt; Terri M Christianson; Pascale M N Tiger; Jillian R Brown; Roger Lawrence; Bryan K Yip; John Holtzinger; Anil Bagri; Danielle Crippen-Harmon; Kristen N Vondrak; Zhi Chen; Chuck M Hague; Josh C Woloszynek; Diana S Cheung; Katherine A Webster; Evan G Adintori; Melanie J Lo; Wesley Wong; Paul A Fitzpatrick; Jonathan H LeBowitz; Brett E Crawford; Stuart Bunting; Patricia I Dickson; Elizabeth F Neufeld
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

2.  Angiotensin receptor blockade mediated amelioration of mucopolysaccharidosis type I cardiac and craniofacial pathology.

Authors:  Mark J Osborn; Beau R Webber; Ronald T McElmurry; Kyle D Rudser; Anthony P DeFeo; Michael Muradian; Anna Petryk; Benedikt Hallgrimsson; Bruce R Blazar; Jakub Tolar; Elizabeth A Braunlin
Journal:  J Inherit Metab Dis       Date:  2016-10-14       Impact factor: 4.982

3.  Enzyme replacement therapy (ERT) procedure for mucopolysaccharidosis type II (MPS II) by intraventricular administration (IVA) in murine MPS II.

Authors:  Takashi Higuchi; Hiromi Shimizu; Takahiro Fukuda; Shiho Kawagoe; Juri Matsumoto; Yohta Shimada; Hiroshi Kobayashi; Hiroyuki Ida; Toya Ohashi; Hideto Morimoto; Tohru Hirato; Katsuya Nishino; Yoshikatsu Eto
Journal:  Mol Genet Metab       Date:  2012-05-18       Impact factor: 4.797

Review 4.  Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau.

Authors:  D R Williams
Journal:  Intern Med J       Date:  2006-10       Impact factor: 2.048

Review 5.  Enzyme replacement therapy in mucopolysaccharidosis type I.

Authors:  E Miebach
Journal:  Acta Paediatr Suppl       Date:  2005-03

6.  Follow-up study of subunit c of mitochondrial ATP synthase (SCMAS) in Batten disease and in unrelated lysosomal disorders.

Authors:  M Elleder; J Sokolová; M Hrebícek
Journal:  Acta Neuropathol       Date:  1997-04       Impact factor: 17.088

7.  Expression of hydroxyindole-O-methyltransferase enzyme in the human central nervous system and in pineal parenchymal cell tumors.

Authors:  Takahiro Fukuda; Nobutake Akiyama; Masahiro Ikegami; Hitoshi Takahashi; Atsushi Sasaki; Hidehiro Oka; Takashi Komori; Yuko Tanaka; Youichi Nakazato; Jiro Akimoto; Masahiko Tanaka; Yoshikazu Okada; Saburo Saito
Journal:  J Neuropathol Exp Neurol       Date:  2010-05       Impact factor: 3.685

Review 8.  Immune tolerance after long-term enzyme-replacement therapy among patients who have mucopolysaccharidosis I.

Authors:  Revecca Kakavanos; Chris T Turner; John J Hopwood; Emil D Kakkis; Doug A Brooks
Journal:  Lancet       Date:  2003-05-10       Impact factor: 79.321

9.  Effects of enzyme replacement therapy started late in a murine model of mucopolysaccharidosis type I.

Authors:  Gabriela Pasqualim; Guilherme Baldo; Talita Giacomet de Carvalho; Angela Maria Vicente Tavares; Roberto Giugliani; Ursula Matte
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

10.  Report of 5 novel mutations of the α-L-iduronidase gene and comparison of Korean mutations in relation with those of Japan or China in patients with mucopolysaccharidosis I.

Authors:  Min Jung Kwak; Rimm Huh; Jinsup Kim; Hyung-Doo Park; Sung Yoon Cho; Dong-Kyu Jin
Journal:  BMC Med Genet       Date:  2016-08-12       Impact factor: 2.103

View more
  4 in total

Review 1.  The Inflammation in the Cytopathology of Patients With Mucopolysaccharidoses- Immunomodulatory Drugs as an Approach to Therapy.

Authors:  Anna-Maria Wiesinger; Brian Bigger; Roberto Giugliani; Maurizio Scarpa; Tobias Moser; Christina Lampe; Christoph Kampmann; Florian B Lagler
Journal:  Front Pharmacol       Date:  2022-05-13       Impact factor: 5.988

Review 2.  Recent trends in mucopolysaccharidosis research.

Authors:  Hiroshi Kobayashi
Journal:  J Hum Genet       Date:  2018-11-19       Impact factor: 3.172

Review 3.  Novel Enzyme Replacement Therapies for Neuropathic Mucopolysaccharidoses.

Authors:  Yuji Sato; Torayuki Okuyama
Journal:  Int J Mol Sci       Date:  2020-01-08       Impact factor: 5.923

Review 4.  Pathogenesis of Mucopolysaccharidoses, an Update.

Authors:  Simona Fecarotta; Antonietta Tarallo; Carla Damiano; Nadia Minopoli; Giancarlo Parenti
Journal:  Int J Mol Sci       Date:  2020-04-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.